Improving Glycemic Control in Adults and Children With Type 1 Diabetes With the Use of Smartphone-Based Mobile Applications: A Systematic Review
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
OBJECTIVES Management of type 1 diabetes is often challenging. Smartphone mobile applications (apps) may provide additional support and help to improve glycemic control and clinical outcomes. The objectives of this study were to examine the literature evaluating the use of mobile apps (stand-alone and text messaging/feedback) in type 1 diabetes and to review top-rated mobile apps applicable to type 1 diabetes. METHODS Medline, Cochrane and Embase databases were systematically searched to identify studies published from inception to February 2018. Top-rated relevant apps from Google Play Store and Apple App Store were reviewed in July 2017. RESULTS The literature search yielded 3,462 studies. Of these studies, 9 evaluated the stand-alone apps; 3 showed significant improvement in glycated hemoglobin (A1C) levels (0.5%, p<0.05, 0.57%, p<0.05, and 0.58%, p=0.02); 3 demonstrated improved adherence to glucose monitoring; and 1 study demonstrated a reduction in hypoglycemic events (glucose<3.0 mmol/L) in 6 of 10 participants who completed the study. Also, 5 studies evaluated a mobile app plus text-messaging/feedback system. Only 1 showed a significant reduction in severe hypoglycemic events (mobile app+text, IQR 0.33, 95% CI 0.17 to 0.63; vs. control, IQR 2.29, 95% CI 1.80 to 2.91), while another single study demonstrated a reduction in median glycated hemoglobin levels (0.3%; p<0.001). Most top-rated mobile apps logged parameters relevant to diabetes management, and some provided graphic analysis and set reminders. CONCLUSIONS This study highlights the need for larger and longer studies to explore the efficacy of apps to optimize outcomes in type 1 diabetes, the populations that would benefit most from these tools and the resources needed to support mobile apps plus text-messaging/feedback systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329
Design of an mHealth app for the self-management of adolescent type 1 diabetes: a pilot study
Cafazzo, J. A., Casselman, M., Hamming, N., Katzman, D. K., & Palmert, M. R. (2012) · Journal of Medical Internet Research · doi:10.2196/jmir.2058 · Cited by 676 · cited 5×
“B. Cochrane Collaboration’s tool for assessing risk of bias for nonrandomized controlled trials (12) A Studies Adequate sequence generation Allocation concealment Blinding Incomplete outcome data addressed Free of selective reporting Free of other bias Charpentier (2011) Unclear Unclear No Yes Yes Yes Kirwan (2013) Un…”
BackgroundMethodInfluential(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.193 · Cited by 653
Quinn, C. C., Shardell, M. D., Terrin, M. L., Barr, E. A., Ballew, S. H., & Gruber-Baldini, A. L. (2011) · Diabetes Care · doi:10.2337/dc11-0366 · Cited by 650
Hou, C., Carter, B., Hewitt, J., Francisa, T., & Mayor, S. (2016) · Diabetes Care · doi:10.2337/dc16-0346 · Cited by 411
Kirwan, M., Vandelanotte, C., Fenning, A., & Duncan, M. J. (2013) · Journal of Medical Internet Research · doi:10.2196/jmir.2588 · Cited by 343
Diabetes Management via Mobile Phones: A Systematic Review
Holtz, B., & Lauckner, C. (2012) · Telemedicine and e-Health · doi:10.1089/tmj.2011.0119 · Cited by 318
Charpentier, G., Benhamou, P.-Y., Dardari, D., Clergeot, A., Franc, S., Schaepelynck-Belicar, P., Catargi, B., Melki, V., Chaillous, L., Farret, A., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1259 · Cited by 292
T2DM Self-Management via Smartphone Applications: A Systematic Review and Meta-Analysis
Cui, M., Wu, X., Mao, J., Wang, X., & Nie, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166718 · Cited by 269 · cited 4×
“The follow-up duration ranged from 3 months to 1 year (9).”
BackgroundMethodInfluentialSmartphone interventions for long-term health management of chronic diseases: an integrative review
Wang, J., Wang, Y., Wei, C., Yao, N. (., Yuan, A., Shan, Y., & Yuan, C. (2014) · Telemedicine and e-Health · doi:10.1089/tmj.2013.0243 · Cited by 215 · cited 2×
“Many mobile apps have the added feature of telemonitoring, which allows for the direct transmission of patients’ data to their health-care teams and that, in turn, facilitates more frequent feedback and support (4).”
BackgroundBaron, J., McBain, H., & Newman, S. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600524 · Cited by 123
Drion, I., Pameijer, L. R., van Dijk, P. R., Groenier, K. H., Kleefstra, N., & Bilo, H. J. G. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815585871 · Cited by 74 · cited 9×
“The meta-analysis by Hou et al reviewed 14 RCTs that had a total of 1,360 participants.”
BackgroundInfluentialRossi, M. C. E., Nicolucci, A., Pellegrini, F., Bruttomesso, D., Bartolo, P. D., Marelli, G., Dal Pos, M., Galetta, M., Horwitz, D., & Vespasiani, G. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0020 · Cited by 69 · cited 5×
“B. Cochrane Collaboration’s tool for assessing risk of bias for nonrandomized controlled trials (12) A Studies Adequate sequence generation Allocation concealment Blinding Incomplete outcome data addressed Free of selective reporting Free of other bias Charpentier (2011) Unclear Unclear No Yes Yes Yes Kirwan (2013) Un…”
BackgroundResultInfluentialImproved A1C Levels in Type 1 Diabetes with Smartphone App Use
Ryan, E. A., Holland, J., Stroulia, E., Bazelli, B., Babwik, S. A., Li, H., Senior, P., & Greiner, R. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.06.001 · Cited by 63 · cited 4×
“Ryan et al studied the use of the Intelligent Diabetes Management app, in which participants recorded their glucose readings, their anticipated carbohydrate intakes and their planned physical activities (27).”
BackgroundMethodResultInfluential
Research works printed but not linked: 13
- 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 · DOI · Paper page
- Nathan, 2005, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes, N Engl J Med, 353, 2643, 10.1056/NEJMoa052187 · DOI · Paper page
- Deacon, 2015, Using mobile technology to motivate adolescents with type 1 diabetes mellitus: A systematic review of recent literature, J Telemed Telecare, 21, 1, 10.1177/1357633X15605223 · DOI · Paper page
- Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement, BMJ, 6, e1000097
- Skrovseth, 2015, Data-driven personalized feedback to patients with type 1 diabetes: A randomized trial, Diabetes Technol Ther, 17, 482, 10.1089/dia.2014.0276 · DOI · Paper page
- Goyal, 2017, A mobile app for the self-management of type 1 diabetes among adolescents: A randomized controlled trial, JMIR Mhealth Uhealth, 5, e82, 10.2196/mhealth.7336 · DOI · Paper page
- Clements, 2017, A Mobile app for synchronizing glucometer data: Impact on adherence and glycemic control among youths with type 1 diabetes in routine care, J Diabetes Sci Technol, 11, 461, 10.1177/1932296817691302 · DOI · Paper page
- Skrovseth, 2012, Mobile phone-based pattern recognition and data analysis for patients with type 1 diabetes, Diabetes Technol Ther, 14, 1098, 10.1089/dia.2012.0160 · DOI · Paper page
- Franc, 2009, Real-life application and validation of flexible intensive insulin-therapy algorithms in type 1 diabetes patients, Diabetes Metab, 35, 463, 10.1016/j.diabet.2009.05.006 · DOI
- Feuerstein-Simon, 2017, Use of a smartphone application to reduce hypoglycemia in type 1 diabetes: A pilot study, J Diabetes Sci Technol
- Froisland, 2012, Improving diabetes care for young people with type 1 diabetes through visual learning on mobile phones: Mixed methods study, J Med Internet Res, 14, e111, 10.2196/jmir.2155 · DOI · Paper page
- Rossi, 2013, Impact of the “Diabetes Interactive Diary” telemedicine system on metabolic control, risk of hypoglycemia, and quality of life: A randomized clinical trial in type 1 diabetes, Diabetes Technol Ther, 15, 670, 10.1089/dia.2013.0021 · DOI · Paper page
- McKay, 2018, Evaluating mobile phone applications for health behaviour change: A systematic review, J Telemed Telecare, 24, 22, 10.1177/1357633X16673538 · DOI · Paper page
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Timpel, P., Oswald, S., Schwarz, P. E. H., & Harst, L. (2020) · Journal of Medical Internet Research · doi:10.2196/16791 · Cited by 243
“digitally supported self-management using phones or apps on HbA1c [42,44,54] and SBP/DBP [40,55].”
BackgroundMethodInfluentialEffectiveness of Disease-Specific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review
Eberle, C., Löhnert, M., & Stichling, S. (2021) · JMIR mHealth and uHealth · doi:10.2196/23477 · Cited by 160
“Sun et al [71] reported on 3 studies that showed a significant improvement in HbA 1c levels, ranging from –0.50% to –0.58%, in people diagnosed with T1DM.”
InfluentialStevens, S., Gallagher, S., Andrews, T., Ashall-Payne, L., Humphreys, L., & Leigh, S. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.936752 · Cited by 84
Metadata
- Authors
- Sun, C., Malcolm, J. C., Wong, B., Shorr, R., & Doyle, M.-A.
- Venue
- Canadian Journal of Diabetes
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 43
- Issue
- 1
- Pages
- 51-58.e3
- ISSN
- 1499-2671 (ISSN-L)
- OpenAlex
- W2794706102
- Cited by
- 52
- References
- 14
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.